May 2024 – Page 22

BridgeBio Secures $200 Million from Venture Capitalists to Propel Oncology Spinout Beyond KRAS Class

12 months ago talkbio0Tagged Biotechnology, BridgeBio, Cancer Therapeutic Procedure, Class, Drug Development, Health care facility, Investments, K-ras Oncogene, KRAS, Neoplasms, venture

BridgeBio, venture capital, oncology, spinout, KRAS class, cancer treatment, biotechnology, drug development, investment, healthcare.

Moderna Terminates Gene Editing Partnership, Shifts Focus to mRNA Technology

12 months ago talkbio0Tagged biobucks, Biotechnology, deal termination, Gene Modification, Metagenomi, Moderna, mRNA technology, Partnership

Moderna, Metagenomi, gene editing, partnership, mRNA technology, biotechnology, biobucks, deal termination

Moderna Maintains Long-Term Vision, Terminates Collaboration with Metagenomi

12 months ago talkbio0Tagged Collaboration termination, first-quarter update, Long-term, Metagenomi, Moderna

Moderna, first-quarter update, long-term strategy, Metagenomi, collaboration termination

Ingrezza, a Neurocrine Biosciences Drug, Receives FDA Approval for Tardive Dyskinesia Treatment

12 months ago talkbio0Tagged Approved, Biosciences, first-of-its-kind, Ingrezza, Neurocrine, Tardive Dyskinesia, United States Food and Drug Administration, valbenazine

Neurocrine Biosciences, Ingrezza, FDA approval, tardive dyskinesia, neuropsychiatric disorder, valbenazine, first-of-its-kind treatment.

Amwell Reports Mixed Q1 Results with Decreased Sales but Narrowed Net Loss

12 months ago talkbio0Tagged Amwell, Sales - occupational activity, Telemedicine

Amwell, Q1 results, sales, net loss, telehealth, digital healthcare

FDA Grants Full Approval to Pfizer’s Tivdak for Advanced Cervical Cancer Treatment

12 months ago talkbio0Tagged Approved, Malignant tumor of cervix, Pfizer, regulatory tracker, Tivdak, United States Food and Drug Administration

FDA, Pfizer, Tivdak, full approval, advanced cervical cancer, treatment, regulatory tracker

The Closure of Walmart Health Highlights Significant Hurdles for Retail Health Innovators

12 months ago talkbio0Tagged accessibility, competition, disruptors, Engaged to be married, Health, Health care facility, innovation, Landscapes, Reparative closure, Walmart Health

Walmart Health, retail health, disruptors, challenges, closure, innovation, healthcare, accessibility, competition, patient engagement, healthcare landscape.

Editas Medicine and Bristol Myers Squibb Expand T Cell Therapy Collaboration; KalVista Pharmaceuticals Seeks Partnership for Preclinical Hereditary Angioedema Program

12 months ago talkbio0Tagged Angioedemas, Hereditary, Collaboration, Editas Medicine, KalVista, Myers, Partnership, preclinical program, squibb, T cell therapy

Editas Medicine, Bristol Myers Squibb, T cell therapy, collaboration, KalVista Pharmaceuticals, preclinical program, hereditary angioedema (HAE), partnership.